Christoph F. Ebenbichler, MD
- 3Articles
- 11.1KReads
- 2003–2009Active
- 21Collaborators
- 7Citations
About
Christoph F. Ebenbichler, MD, has published research on the metabolic effects of psychiatric treatments, focusing on conditions such as schizophrenia and schizoaffective disorders. His work includes studies on antipsychotic-induced hyperprolactinemia, the impact of mirtazapine on body composition and metabolism, and olanzapine-related insulin resistance. Ebenbichler's articles appeared between 2003 and 2009 in Psychiatrist.com, often collaborating with co-authors including Josef R. Patsch and W. Wolfgang Fleischhacker.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
